Company Profile (AI Text)
Name: Seattle Gummy Company
Canonical URL: https://wefunder.com/seattle.gummy.company
Updated at: 2026-06-02T23:52:49Z

Tagline: Delivering functional healthcare with gummies instead of pills
Elevator pitch: We are a specialty pharmaceutical company focusing on delivering medicine and bioactives using gummmy formulations. Chewable gummy formulation is perfect for delivering medications, and not just for children. Did you know that 30% of the populations have problem swallowing pills and capsules? Our gummy medicines could significantly improve medication efficiency and patients’ compliance.

Key claims:
- Total raised on Wefunder: 675389 | citation: https://wefunder.com/seattle.gummy.company#claim-total-raised
- Total investors: 146 | citation: https://wefunder.com/seattle.gummy.company#claim-total-investors

Verified facts:
- Total raised on Wefunder: 675389 | observed_at: 2026-06-02T23:52:49Z | expires_at: 2026-06-03T23:52:49Z
- Total investors: 146 | observed_at: 2026-06-02T23:52:49Z | expires_at: 2026-06-03T23:52:49Z

Computed metrics:
- total_amount_raised: 675389
- total_investors: 146
- team_size: 6
- featured_investor_count: 1
- faq_count: 2
- recent_post_count: 0

Quick facts:
- Pill protestors rejoice, no more swallowing horse pill, no more sticky spilly syrup | citation: https://wefunder.com/seattle.gummy.company#claim-fact-1
- Received the IND approval from FDA on the world first ever gummy medicine | citation: https://wefunder.com/seattle.gummy.company#claim-fact-2
- 10+ gummy medicine developed, 5 in FDA approval process, and 16+ functional gummy products in stores | citation: https://wefunder.com/seattle.gummy.company#claim-fact-3
- 70+ Patent filings with 40+ patents pending and 30 International Trademarks | citation: https://wefunder.com/seattle.gummy.company#claim-fact-4
- $10M+ Raised from VC, PE and FOs; and R&D collaborations with Fortune500 partners | citation: https://wefunder.com/seattle.gummy.company#claim-fact-5
- Endless revenue generation: Functional Gummies, Gummy Medicine, IP licensing, R&D service | citation: https://wefunder.com/seattle.gummy.company#claim-fact-6
- Poised to address a $1200B dollar global pharmaceutical market or TAM | citation: https://wefunder.com/seattle.gummy.company#claim-fact-7
- In 4500+ stores across US, e-commerce to all 50 States and in China with $2.5M revenue to date | citation: https://wefunder.com/seattle.gummy.company#claim-fact-8

FAQ:
- Q: if we invest would that mean we also would own the IP and merchandising.
  A: Hey Abdalla, Thanks for your inquiries. The company owns all the IP and merchandising. Shareholders own the company. Thanks again. Connie
- Q: In a previous response you said "Wefunder investors will have the same terms as institutional investors from the larger Series B raise, which is on goin,." however I can not find anything that dictates what the terms of the institutional investors. Can you please detail what t...
  A: Hey Josh, Thanks for your inquiry. My apologies for delay in responding. The current term that we are offering to the institutional investors for Series B is $56M pre-money, $19.20/preferred share. The term has been submitted to weFunder. However, I believe that weFunder is waiting for the audited financials to file Form C with the SEC. Once Form C is filed, the term sheet will be locked and accessible to the weFunder investors. Thanks so much again. Connie